Together, these two technologies have the potential to revolutionize health care. AVITA Medical x Matregenix: Accelerating Innovation Through
AVITA Medical is revolutionizing skin healing, reducing recovery time, and improving outcomes for burn victims and those with vitiligo. Niraj Doshi, Senior VP of New Product Development, highlighted the positive impact of ULP’s ecosystem and network on the companies in recent years. With full access to advanced equipment at ULP’s shared wet- lab space, AVITA’s expanding team focuses on enhancing clinical results with their FDA-approved RECELL® System technology platform. This platform harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin™ cells. Delivered at the point-of-care, RECELL enables improved clinical outcomes. RECELL is the catalyst of a new treatment paradigm and AVITA Medical is leveraging its proven and differentiated capabilities to develop first-in-class cellular therapies for multiple indications.
As a testament to one of the advantages of working in an incubator environment, Dr. Doshi and his team support and mentor new start-ups and have partnered with Matregenix, another ULP Resident company, to investigate and work on a new project together. Matregenix is a global leader in nanofiber technology, offering highly customizable nanofibrous materials for a diverse range of applications. They are constantly pushing the boundaries of nanofiber technology with cutting-edge platforms, focusing specifically on filtration and biomedical fields. Together, these two technologies have the potential to revolutionize health care.
15 University Lab Partners 2023 Annual Report | Breakthroughs Today, Careers Tomorrow
Made with FlippingBook - Online catalogs